Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Chinese Medical Journal|January 19, 2010
Value of abdominal ultrasound scan, CT and MRI for diagnosing inferior vena cava tumour thrombus in renal cell carcinomaHong-feng Guo, Yi Song, Yan-qun Na
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|May 21, 2013
Multilayer scaffold of electrospun PLA-PCL-collagen nanofibers as a dural substituteYu-fei Wang, Hong-feng Guo, Da-jun Ying
International Journal of Clinical and Experimental Medicine|August 27, 2015
Rapid evolving into acute myeloid leukemia in a patient with multiple myeloma and concurrent myelodysplasia after VTD therapyZhong-Hua Gu, Xin Xie, Jing-Jue Mao, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|March 1, 2017
[Influence of Chromosome Abnormality on Therapeutic Efficacy and Prognosis of Newly Diagnosed Multiple Myeloma Treated with Bortezomib]Chao Sun, Jing Wang, Hong-Feng Guo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 8, 2022
The prognostic value of the controlling nutritional status score in patients with myelodysplastic syndromeJin Qian, Jing Wang, Feng Cheng, et al.
Clinical Laboratory|May 9, 2018
Limited Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratios in Elderly Patients with Multiple MyelomaJing Wang, Jue Wang, Chao Sun, et al.
Asian Journal of Surgery|September 28, 2023
Influence of pulling direction on knot security: A laboratory researchHong-Feng Guo, Xiao-Yu Hou, Wei-Wei Dai, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|December 20, 2008
[Urodynamic analysis of dysuria in female patients]Hong-feng GUO, Ji-hong DUAN, Yun-xiang XIAO, et al.
Chinese Medical Journal|July 26, 2016
Clinical Manifestation of Calreticulin Gene Mutations in Essential Thrombocythemia without Janus Kinase 2 and MPL Mutations: A Chinese Cohort Clinical StudyChao Sun, Xin Zhou, Zhi-Jian Zou, et al.
Oncology Letters|October 23, 2018
Association of CD117 and HLA-DR expression with shorter overall survival and/or progression-free survival in patients with multiple myeloma treated with bortezomib and thalidomide combination treatment without transplantationHuan Wang, Xin Zhou, Jian-Wei Zhu, et al.
Pageof 3